ACE2 News and Research

RSS
Mouse model of fatal COVID-19 developed for vaccine and drug testing

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Analysis of the SARS-CoV-2 proteome via visual tools

Analysis of the SARS-CoV-2 proteome via visual tools

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Examining cardiovascular injuries in patients who recovered from COVID-9 infection

Examining cardiovascular injuries in patients who recovered from COVID-9 infection

More COVID-19 cases where blood type A is common

More COVID-19 cases where blood type A is common

New insight into the SARS-CoV-2 infection process

New insight into the SARS-CoV-2 infection process

Study shows fused lung cells are pervasive in severe COVID-19

Study shows fused lung cells are pervasive in severe COVID-19

Compelling study shows heparin may protect against COVID-19

Compelling study shows heparin may protect against COVID-19

Prominent pharmacologist calls for new approach to treat COVID-19

Prominent pharmacologist calls for new approach to treat COVID-19

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Children with MIS-C have different antibody responses than adults with COVID-19

Children with MIS-C have different antibody responses than adults with COVID-19

Study explains why fetuses and newborns are mostly spared by COVID-19

Study explains why fetuses and newborns are mostly spared by COVID-19

Study provides new insights into genetic susceptibility of COVID-19

Study provides new insights into genetic susceptibility of COVID-19

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Common FDA-approved drug may be a powerful tool in fighting COVID-19

Common FDA-approved drug may be a powerful tool in fighting COVID-19

Study: Amount of SARS-Cov-2 receptor is increased in patients with pre-existing cardiac conditions

Study: Amount of SARS-Cov-2 receptor is increased in patients with pre-existing cardiac conditions

Mobility and flexibility in SARS-CoV-2 proteins

Mobility and flexibility in SARS-CoV-2 proteins

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Llama nanobodies block SARS-CoV-2 infection in vitro

Llama nanobodies block SARS-CoV-2 infection in vitro

Cold sensitivity of SARS-CoV-2 could impact vaccine studies

Cold sensitivity of SARS-CoV-2 could impact vaccine studies